F

Amicus Therapeutics
D

FOLD

9.43000
USD
0.07
(0.75%)
مغلق
حجم التداول
59,430
الربح لكل سهم
0
العائد الربحي
-
P/E
-28
حجم السوق
2,817,738,439
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ARWR
    0.540
    (2.84%)
    19.560 USD
    B
    BLUE
    0.05000
    (0.60%)
    8.35000 USD
    C
    CRSP
    0.260
    (0.65%)
    40.520 USD
    E
    EDIT
    -0.03000
    (-2.40%)
    1.22000 USD
    N
    NTLA
    0.09000
    (0.96%)
    9.50000 USD
    Q
    QURE
    -0.190
    (-1.33%)
    14.050 USD
    S
    SGMO
    -0.00500
    (-0.45%)
    1.10000 USD
    S
    SRPT
    1.070
    (0.91%)
    118.040 USD
    VRTX
    VRTX
    4.97
    (1.19%)
    422.10 USD
    المزيد
الأخبار
المقالات

العنوان: Amicus Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.